These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 23557985)
1. Cell viability score (CVS) as a good indicator of critical concentration of benzalkonium chloride for toxicity in cultured ocular surface cell lines. Iwasawa A; Ayaki M; Niwano Y Regul Toxicol Pharmacol; 2013 Jul; 66(2):177-83. PubMed ID: 23557985 [TBL] [Abstract][Full Text] [Related]
2. Cell viability score as an integrated indicator for cytotoxicity of benzalkonium chloride-containing antiglaucoma eyedrops. Ayaki M; Iwasawa A; Niwano Y Biocontrol Sci; 2012; 17(3):121-8. PubMed ID: 23007103 [TBL] [Abstract][Full Text] [Related]
3. In vitro assessment of the cytotoxicity of anti-allergic eye drops using 5 cultured corneal and conjunctival cell lines. Ayaki M; Iwasawa A; Yaguchi S; Koide R J Oleo Sci; 2011; 60(3):139-44. PubMed ID: 21343662 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of in vitro ocular surface cytotoxicity of a fixed combination of 0.5% timolol/1% dorzolamide eyedrop and its components with 0.005% benzalkonium chloride. Ayaki M; Iwasawa A; Niwano Y Biocontrol Sci; 2012; 17(3):115-20. PubMed ID: 23007102 [TBL] [Abstract][Full Text] [Related]
5. Cell viability of four corneoconjunctival cell lines exposed to five preservatives and a surfactant used for infection control in eyedrops. Ayaki M; Iwasawa A Biocontrol Sci; 2011 Sep; 16(3):117-21. PubMed ID: 21946322 [TBL] [Abstract][Full Text] [Related]
6. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells. Ammar DA; Noecker RJ; Kahook MY Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366 [TBL] [Abstract][Full Text] [Related]
7. Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. Epstein SP; Ahdoot M; Marcus E; Asbell PA J Ocul Pharmacol Ther; 2009 Apr; 25(2):113-9. PubMed ID: 19284328 [TBL] [Abstract][Full Text] [Related]
8. Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells. Ammar DA; Noecker RJ; Kahook MY Adv Ther; 2011 Jun; 28(6):501-10. PubMed ID: 21603985 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation. Pauly A; Roubeix C; Liang H; Brignole-Baudouin F; Baudouin C Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8172-80. PubMed ID: 23150620 [TBL] [Abstract][Full Text] [Related]
10. Toxicity of cosmetic preservatives on human ocular surface and adnexal cells. Chen X; Sullivan DA; Sullivan AG; Kam WR; Liu Y Exp Eye Res; 2018 May; 170():188-197. PubMed ID: 29486163 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of benzalkonium chloride toxicity in a human trabecular meshwork cell line and the protective role of preservative-free tafluprost. Chang C; Zhang AQ; Kagan DB; Liu H; Hutnik CM Clin Exp Ophthalmol; 2015 Mar; 43(2):164-72. PubMed ID: 25041649 [TBL] [Abstract][Full Text] [Related]
12. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination. Brignole-Baudouin F; Riancho L; Liang H; Nakib Z; Baudouin C J Ocul Pharmacol Ther; 2011 Jun; 27(3):273-80. PubMed ID: 21410334 [TBL] [Abstract][Full Text] [Related]
13. Preserved and unpreserved 12 anti-allergic ophthalmic solutions and ocular surface toxicity: in vitro assessment in four cultured corneal and conjunctival epithelial cell lines. Ayaki M; Iwasawa A; Yaguchi S; Koide R Biocontrol Sci; 2010 Dec; 15(4):143-8. PubMed ID: 21212507 [TBL] [Abstract][Full Text] [Related]
14. Benzalkonium chloride-induced direct and indirect toxicity on corneal epithelial and trigeminal neuronal cells: proinflammatory and apoptotic responses in vitro. Vitoux MA; Kessal K; Melik Parsadaniantz S; Claret M; Guerin C; Baudouin C; Brignole-Baudouin F; Réaux-Le Goazigo A Toxicol Lett; 2020 Feb; 319():74-84. PubMed ID: 31707104 [TBL] [Abstract][Full Text] [Related]
15. Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage. Pauly A; Meloni M; Brignole-Baudouin F; Warnet JM; Baudouin C Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1644-52. PubMed ID: 19168896 [TBL] [Abstract][Full Text] [Related]
16. Effects of 20% Human Serum on Corneal Epithelial Toxicity Induced by Benzalkonium Chloride: In Vitro and Clinical Studies. Moon J; Ko JH; Yoon CH; Kim MK; Oh JY Cornea; 2018 May; 37(5):617-623. PubMed ID: 29300263 [TBL] [Abstract][Full Text] [Related]
17. In vitro assessment of the cytotoxicity of six topical antibiotics to four cultured ocular surface cell lines. Ayaki M; Iwasawa A; Niwano Y Biocontrol Sci; 2012 Jun; 17(2):93-9. PubMed ID: 22790846 [TBL] [Abstract][Full Text] [Related]
18. Cationorm shows good tolerability on human HCE-2 corneal epithelial cell cultures. Kinnunen K; Kauppinen A; Piippo N; Koistinen A; Toropainen E; Kaarniranta K Exp Eye Res; 2014 Mar; 120():82-9. PubMed ID: 24462278 [TBL] [Abstract][Full Text] [Related]
19. The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells. Datta S; Baudouin C; Brignole-Baudouin F; Denoyer A; Cortopassi GA Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2406-2412. PubMed ID: 28444329 [TBL] [Abstract][Full Text] [Related]